Endovascular therapy versus best medical treatment for symptomatic intracranial atherosclerotic stenosis: A systematic review and meta-analysis
European Stroke Journal · 01.09.2025 · 10 (3) · 655-664
DOI: 10.1177/23969873251324863 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Stroke Journal, online erschienen am 01.09.2025. Verfasst von Maria-Ioanna Stefanou und 16 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Intracranial Arteriosclerosis, Endovascular Procedures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Evidence on endovascular therapy (EVT) for symptomatic intracranial stenosis (sICAS) from randomized-controlled clinical trials (RCTs) is conflicting. While prior RCTs on percutaneous transluminal angioplasty and stenting (PTAS) demonstrated harm or no benefit over best medical treatment (BMT), recent data suggest that submaximal balloon angioplasty with BMT may be superior to BMT alone. Patients and methods A systematic review and meta-analysis of RCTs was conducted to evaluate the safety and efficacy of elective EVT plus BMT compared to BMT alone for sICAS.
Results
Six RCTs (5 on PTAS and 1 on balloon-angioplasty) comprising 1606 patients were included. EVT increased the risk of any stroke or death (RR = 2.68; 95% CI: 1.72–4.19; I2 = 0%), ischemic stroke within the territory of the qualifying artery (RR = 2.51; 95% CI: 1.36–4.61; I2 = 0%), any ischemic stroke (RR = 1.99; 95% CI: 1.17–3.38; I2 = 0%), intracranial hemorrhage (RR = 6.23; 95% CI: 1.92–20.2; I2 = 0%), and mortality (RR = 3.52; 95% CI: 1.04–11.88; I2 = 0%) within 30 days. No significant benefit from EVT was detected regarding the risk of any stroke or death (RR = 0.29, 95% CI: 0.06–1.38; I2 = 68%), ischemic stroke in the territory of the qualifying artery (RR = 0.44, 95% CI: 0.14–1.33; I2 = 59%) and mortality (RR = 0.49, 95% CI: 0.16–1.55; I2 = 0%) beyond 30 days through 1 year. Discussion and conclusion EVT is associated with adverse early outcomes, without reducing the risk of long-term stroke recurrence or mortality compared to BMT. Further research is warranted to identify high-risk subgroups who may benefit from EVT for sICAS and refine interventions to minimize periprocedural risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Neurology & Stroke, Eberhard-Karls University of Tübingen, Tübingen, Germany.
- Interventional Neuroradiology Unit, Metropolitan Hospital, Piraeus, Greece.
- Interventional Radiology Unit, Second Department of Radiology, "Attikon" University General Hospital, Athens, Greece.
- Stroke Unit, Metropolitan Hospital, Piraeus, Greece.
- Second Department of Anesthesiology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Lina Palaiodimou, Odysseas Kargiotis, Tatiana Sidiropoulou, Ulf Ziemann, Georgios Tsivgoulis
Zitieren
APA
Stefanou, M. I., Panagiotopoulos, E., Palaiodimou, L., Theodorou, A., Magoufis, G., Spiliopoulos, S., Safouris, A., Kargiotis, O., Psychogios, K., Sidiropoulou, T., Frantzeskaki, F., Mitsias, P. D., Feil, K., Mengel, A., Themistocleous, M., Ziemann, U., & Tsivgoulis, G. (2025). Endovascular therapy versus best medical treatment for symptomatic intracranial atherosclerotic stenosis: A systematic review and meta-analysis. European Stroke Journal, 10(3), 655-664. https://doi.org/10.1177/23969873251324863
Vancouver
Stefanou MI, Panagiotopoulos E, Palaiodimou L, Theodorou A, Magoufis G, Spiliopoulos S, et al. Endovascular therapy versus best medical treatment for symptomatic intracranial atherosclerotic stenosis: A systematic review and meta-analysis. European Stroke Journal. 2025;10(3):655-664. doi:10.1177/23969873251324863
BibTeX
@article{Stefanou2025,
author = {Stefanou, Maria-Ioanna and Panagiotopoulos, Evangelos and Palaiodimou, Lina and Theodorou, Aikaterini and Magoufis, George and Spiliopoulos, Stavros and Safouris, Apostolos and Kargiotis, Odysseas and Psychogios, Klearchos and Sidiropoulou, Tatiana and Frantzeskaki, Frantzeska and Mitsias, Panayiotis D and Feil, Katharina and Mengel, Annerose and Themistocleous, Marios and Ziemann, Ulf and Tsivgoulis, Georgios},
title = {Endovascular therapy versus best medical treatment for symptomatic intracranial atherosclerotic stenosis: A systematic review and meta-analysis},
journal = {European Stroke Journal},
year = {2025},
volume = {10},
number = {3},
pages = {655--664},
doi = {10.1177/23969873251324863}
}
EUVIMED